ABUS (arbutusbio.com) Rasio Nilai Pasar marang Nilai Buku

Simbol resmi perusahaan Arbutus Biopharma Corp (ABUS)

Arbutus Biopharma (ABUS) is a biopharmaceutical player developing hepatitis B therapies amidst intense patent litigation. Current price action on GURU.Markets, which stands at 3.32, links the company's profile to its markets: patients and partners who generate revenue through LNP technology royalties. Proprietary rights for RNA drug delivery provide a strong economic moat, despite the costs associated with legal disputes.

ABUS Tekmira Pharmaceuticals: Nilai Pasar marang Nilai Buku ing interval 04.07.2022 - 28.10.2026

Rincian metrik keuangan lan pasar Arbutus Biopharma Corp (ABUS)

- rega lan prakiraan konsensus rega:
Bagan rega Arbutus Biopharma|ABUS - Target median analis
- data kapitalisasi pasar:
Nilai pasar Arbutus|ABUS - Nilai Wutuh Bisnis
- data kapitalisasi buku:
Nilai Buku saben Saham Arbutus Biopharma|ABUS - Nilai Akuntansi Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku arbutusbio.com|ABUS - Total Aset Perusahaan
- data utang lan likuiditas:
Utang marang Ekuitas Arbutus Biopharma|ABUS - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Arbutus|ABUS - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Arbutus|ABUS - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Arbutus Biopharma
Analisis wiwitan perusahaan:Arbutus Biopharma - ABUS
Produk asli Arbutus

Investors assess capital risks via net asset value to determine the market premium over the business's actual value. Amid geopolitical isolation and the disruption of clinical trial logistics, Arbutus Biopharma (ABUS) is losing development momentum, which is reflected in the company's P/B ratio: an increase in the metric signals inflated expectations, while a decrease indicates a reassessment of fundamental threats and a decline in investment interest.

Pesaing utama

Arrowhead Pharmaceuticals - Rasio Nilai Pasar marang Nilai Buku|MIRM (mirumpharma.com) - Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku dynavax.com DVAX|Kapitalisasi Pasar marang Aset Bersih Inventiva SA|Gyre Corp (GYRE) - Rasio Kapitalisasi Pasar marang Nilai Buku|Nilai Pasar marang Nilai Buku Assembly Corp (ASMB)|Rasio Kapitalisasi Pasar marang Nilai Buku GALT (Galectin Therapeutics Inc.)|Genfit SA - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku DURECT Corp. (DRRX)|ALGS: Nilai Pasar marang Nilai Buku|BIVI (biovieinc.com) - Rasio Nilai Pasar marang Nilai Buku|Galmed Pharmaceuticals Ltd. (GLMD) - Rasio Kapitalisasi marang Aset Bersih|NDRA (ENDRA Life Sciences) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku Hepion Pharma (HEPA)